Sensus Healthcare, Inc.(NASDAQ:SRTS) reported that its second quarter results were primarily impacted by the timing of ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Revenues in the second quarter of 2026 were $1.9 million, up 116% compared to 894 thousand in the second quarter of 2025. Unit deliveries increased 60% year over year due to the Category I CPT code ...

Good morning, and welcome to the Q2 2026 Acarix Earnings Call. I appreciate everybody joining. For our new investors and for those who have been with us a while, I always like to start out with a ...

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2026.

IceCure Medical Ltd (ICCM-1.39%) reported $1.8 million in revenue for the first half of 2026, a 45% increase driven by higher ...

Inspire Medical Systems INSP is well-positioned for solid growth over the next few quarters as it navigates a significant ...

Explore the evolution of Madras from weaving to AI, highlighting its technological advancements and industrial growth throughout history.

Paxman breaks the 100 MSEK barrier for the first time in a record-breaking Q2! Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of ...

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the second quarter and first half 2026. The report highlights continued commercia ...

The company is heading toward earnings with one growth engine still running hot, while Bank of America sees another potential ...